Denali Therapeutics Inc. (DNLI) Revenue 2016–2025
Denali Therapeutics Inc. (DNLI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2025 · since FY2016: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $330.5M | +214.6% |
| FY2022 | $105.1M | +115.9% |
| FY2021 | $48.7M | -85.5% |
| FY2020 | $335.6M | +1174.9% |
| FY2019 | $26.3M | -79.6% |
| FY2018 | $129.1M | — |
| FY2017 | $0 | — |
| FY2016 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice